| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
230 |
| issn |
1179-1918
1173-2563 |
| issueIdentifier |
4 |
| pageRange |
219-230 |
| publicationName |
Clinical Drug Investigation |
| startingPage |
219 |
| bibliographicCitation |
Daly MP. Quality of life in sexually active men with symptomatic benign prostatic hyperplasia : effects of treatment. Clin Drug Investig. 2005;25(4):219–30. doi: 10.2165/00044011-200525040-00001. PMID: 17523772. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acd0a4691e1eea937631606e314dc744 |
| date |
200504 |
| identifier |
https://doi.org/10.2165/00044011-200525040-00001
https://pubmed.ncbi.nlm.nih.gov/17523772 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1179-1918
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33140
https://portal.issn.org/resource/ISSN/1173-2563 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Quality of life in sexually active men with symptomatic benign prostatic hyperplasia : effects of treatment |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129211
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8982
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9200
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11347 |